Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022)

Precigen (PGEN) posted quarterly Liabilities from Discontinued Operations of 11448000.0 for Q2 2022, up 11123.53% year-over-year from N/an in Q2 2021, and down 10.92% quarter-over-quarter from 12851000.0 in Q4 2021.

Analysis

Precigen (PGEN) Liabilities from Discontinued Operations (2018 - 2022) Analysis & Trends

Precigen (PGEN) has reported Liabilities from Discontinued Operations for 5 consecutive years, with 11448000.0 the latest figure, recorded in Q2 2022.

  • In Q2 2022, Liabilities from Discontinued Operations rose 11123.53% year-over-year to 11448000.0; the TTM figure through Jun 2022 stood at 11448000.0 (up 11123.53% YoY), while the FY2021 annual figure was 12851000.0, down 8.51% from the prior year.
  • Liabilities from Discontinued Operations retreated to 11448000.0 in Q2 2022 per PGEN's latest filing, from 12851000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 50538000.0 in Q4 2019 and bottomed at 102000.0 in Q2 2021.
  • Historically, Liabilities from Discontinued Operations has averaged 14302285.71 across 5 years, with a median of 11448000.0 in 2022.
  • Annual changes were most pronounced in 2020 — Liabilities from Discontinued Operations plunged 72.21% — and 2022, when it surged 11123.53%.
  • Precigen's Liabilities from Discontinued Operations stood at 10958000.0 in 2018, then surged by 361.2% to 50538000.0 in 2019, then slumped by 72.21% to 14047000.0 in 2020, then slipped by 8.51% to 12851000.0 in 2021, then fell by 10.92% to 11448000.0 in 2022.
  • Business Quant data shows PGEN's Liabilities from Discontinued Operations at 11448000.0 in Q2 2022, 12851000.0 in Q4 2021, and 102000.0 in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 11.45 Mn
Dec 31, 2021 12.85 Mn
Jun 30, 2021 102,000.00
Mar 31, 2021 172,000.00
Dec 31, 2020 14.05 Mn
Dec 31, 2019 50.54 Mn
Dec 31, 2018 10.96 Mn